Healthcare & Life Sciences

Foamix Pharmaceuticals Ltd

series-c-plus
series-c-plus
Stage
1
Investors

About

Foamix Pharmaceuticals Ltd develops and commercializes proprietary topical minocycline foam formulations for the treatment of acne, impetigo, and other dermatological conditions.

Explore Foamix Pharmaceuticals Ltd's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.